RT Journal Article
SR Electronic
T1 Improvements in diarrheal disease prevalence with point-of-use water filter implementation in the informal settlement of Kibera, Kenya
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.03.03.23286740
DO 10.1101/2023.03.03.23286740
A1 Tintle, Nathan L.
A1 Westra, Jason
A1 Van De Griend, Kristin
A1 Beard, Virginia
A1 Turner, Benjamin N.
A1 Huisman, Natalie L.H.
A1 Dawson, Nicholas
A1 Droscha, Lillian
A1 Ihle, Clay
A1 Moore, Matthew
A1 Orellana, Marilyn
A1 Schutter, Luke
A1 Snyder, Lydia
A1 White, Devin
A1 Wilson, Makayla
A1 Goszkowicz, Grace K.
A1 Krueger, Brent P.
A1 Best, Aaron A.
YR 2023
UL http://medrxiv.org/content/early/2023/03/05/2023.03.03.23286740.abstract
AB Background There is increasing evidence of the efficacy of point-of-use water filters on diarrhea prevalence in numerous global settings, in both observational studies and randomized experiments. Most studies, however, are focused on rural locations. Methods We use self-report household surveys to monitor a set of approximately 10,000 households receiving point-of-use water filters and WASH training in Kibera, Kenya. Twenty-five drinking water sources throughout the 7 neighborhoods were also selected for testing of E. coli, total coliform, bacterial 16S rRNA community sequencing and metals. Albendazole was provided to all households at distribution as part of the standard filter distribution protocol, with a subset of 2,642 households not receiving Albendazole at distribution, instead receiving it at the second follow-up (approximately 5 weeks after filter distribution).Results After data cleaning, a sample of 6,795 households were analyzed using mixed effects generalized linear models to account for repeated household measurements, geospatial and temporal effects, interviewer and other household covariates. Models predicted self-reported, 2-week prevalence of diarrhea. After accounting for confounding factors, self-reported diarrhea rates dropped from 52.7% to 2.2% after approximately 70 days of filter use. Field testing characterized most water sources (18 out of 25) as unsafe for Total coliforms, many for E. coli (6 out of 25), and one source above WHO health guidelines for arsenic. There was no evidence of a difference in self-reported diarrhea prevalence between households receiving Albendazole at distribution vs. those that didn’t (p>0.05).Conclusions The introduction of Sawyer filters to households in a densely populated informal settlement reduced diarrhea and other health related problems. Representative water quality testing indicates a high frequency of drinking water source contamination with E. coli and Total Coliforms but a very low frequency of dissolved metals present, above WHO guidelines for drinking water. Anti-parasitic medication distribution had little to no impact on the results. Future randomized controlled studies with objective health measures are needed to ensure cause-effect impact of the filters, and study of filter longevity in the field continues to be a critical need.Competing Interest StatementPortions of the authors time (NT, JW, KDVG, BPK, VB and AAB) were supported by a grant from Sawyer Products, Inc.Funding StatementPortions of the authors time (NT, JW, KDVG, BPK, VB and AAB) were supported by a grant from Sawyer Products, Inc.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Data collection procedures were approved by the Institutional Review Board at Dordt University (a federally compliant IRB: FWA00028884), by contract. All participants included in this manuscript consented to participate.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesSummary and/or de-identified data is available from the corresponding author (ntintle{at}uic.edu) upon reasonable request.CBT EC + TC(Compartment Bag Test)(MPN)Most Probable Number(PoC)Point-of-Collection(PoE)Point-of-Entry(PoU)Point-of-Use(TBM)The Bucket Ministry(WASH)Water, sanitation, and hygiene(WHO)World Health Organization